UNSPSC 51452400: Anthelmintic carbamates

Anthelmintic drugs made from derivatives of carbamic acid, H2NC(=O)OH.

UNSPSC 51452400 Anthelmintic carbamates is a Class code that nominally describes parasiticide pharmaceuticals, but recent state and local procurement activity under this code shows little alignment with that scope. The two most recent opportunities tagged to this code involve naloxone (an opioid antagonist), safe drug deactivation systems, doxycycline hyclate (an antibiotic), and ciprofloxacin hydrochloride (a fluoroquinolone antibiotic)—none of which are anthelmintic carbamates. State and local procurement offices appear to be using this code as a catch-all pharmaceutical supply classification rather than for its specific narrower product family. Issuing bodies include state health departments and county public health authorities pursuing pharmaceutical and medical-supply contracts through both piggybacking on existing vendor agreements and standalone competitive bidding processes.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for antibiotics (doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets), with a 12-month initial term and optional renewal years. Seminole County, Florida released an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year contract term plus one-year renewal option. Activity under this code appears concentrated in Florida and Illinois; the mismatch between the code's nominal scope and the products actually being procured suggests that state and local procurement systems may be applying this classification inconsistently across pharmaceutical supply categories.